Association of obesity and central obesity with breast cancer risk in pre- and postmenopausal women

Journal of Babol University of Medical Sciences

Volumn 15, Issue 3, 2013, Pages 7-15

  Hajian, K ^a   Gholizadehpasha, A ^a   Bozorgzadeh, Sh ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body mass index; Breast cancer; Central obesity; Obesity; Overweight; Women

Indexed keywords

EID: 84940329066     PISSN: 15614107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Oqden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295(13): 1549-55.
2. Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004;23(38):6365-78.
3. Osorio-Costal F, Rochal GZ, Diasl MM, Carvalheira GC. Epidemiological and molecular mechanisms aspects linking obesity and cancer. Arq Bras Endocrinol Metabol 2009;53(2):213-26.
4. American Cancer Society. Breast cancer facts & figures 2009-2010. http://www.cancer.org/research/ cancerfactsfigures/breastcancerfactsfigures/breast-cancer-facts--figures-2009-2010 accessed Feb 18, 2013.
5. Okobia MN, Bunker CH, Okonofua FE, Osime U. Knowledge, attitude and practice of Nigerian women towards breast cancer: a cross-sectional study. World J Surg Oncol 2006;4:11.
6. Taleghani F, Yekta ZP, Nasrabadi AN. Coping with breast cancer in newly diagnosed Iranian women. J Adv Nurs 2006;54(3):265-72.
7. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekzadeh R, Parkin DM. Cancer occurrence in Iran in 2002: an international perspective. Asian Pac J Cancer Prev 2005;6(3):359-63.
8. Harirchi I, Karbakhsh M, Kasrefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev 2004;5(1):24-7.
9. Yavari P, Mosavizadeh MA, Sadrolhefazi B, Khodabakhshi R, Madani H, Mehrabi Y. Reproductive characteristics and the risk of breast cancer: A case-control study. Iran J Epidemiol 2006;1(2): 11-19. [in Persian]
10. Hajian K, Firouzjahi AR, Kia MT. Pattern of age distribution of different cancers in Babol, 2001. Journal of The Shaheed Beheshti University of Medical Sciences And Health Services 2003;27(3):239-45.
11. Carter JC, Church FC. Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1. PPARRes, 2009: doi:10.1155/2009/345320.
12. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6(10):772-83.
13. Fantuzzi G. Adipose tissue, adipokines and inflammation. J. Allergy Clin. Immunol 2005;115(5):911-19.
14. Chavey C, Bibeau F, Gourgou-Bourgade S, et al. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 2007;9(1):R15.
15. Okumura M, Yamamoto M, Sakuma H, et al. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression. Biochim Biophys Acta 2002;1592(2): 107-16.
16. Lahmann PH, Lissner L, Gullberg B, Berglund G. A prospective study of adiposity and all-cause mortality: the Malmö Diet and Cancer Study. Obes Res 2002;10(5):361-9.
17. Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2004;111(5):762-71.
18. Chow LW, Lui KL, Chan JC, et al. Association between body mass index and risk of formation of breast cancer in Chinese women. Asian Surg 2005;28(3):179-84.
19. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001;10(1): 15-32.
20. Hajian-Tilaki KO, Heidari B. Prevalence of obesity, central obesity and the associated factors in urban population aged 20-70 years in the north of Iran: a population study and regression approach. Obes Rev 2007;8(1):3-10.
21. Montazeri A, Sadighi J, Farzadi F, et al. Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study. BMC Cancer 2008;8:278.
22. Renehan AG, Roberts DL, Dive C. Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 2008;114(1):71-83.
23. Sonnenschein E, Toniolo P, Terry MB, et al. Body fat distribution and obesity in pre-and postmenopausal breast cancer. Int J Epidemiol 1999;28(6): 1026-31.
24. Nemesure B, Wu SY, Hennis A, Leske MC; Barbados National Cancer Study Group. Body size and breast cancer in a black population--the Barbados National Cancer Study. Cancer Causes Control 2009;20(3):387-94.
25. Goodman MT, Nomure AM, Wikens LR, Hankin J. The Association of diet, obesity, and breast cancer in Hawaii. Cancer Epidemiol, Biomarkers Prev 1992;1(4): 269-75.
26. Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH., Yu CP, Yu JC, Sun CA. Circulating levels of leptin, adiposity and breast cancer risk. Br J Cancer 2009;100(4): 578-82.
27. Oqundiran TO, Huo D, Adenipekun A, et al. Body fat distribution and breast cancer risk: finding from the Nigerian breast cancer study. Cancer Causes Control 2012;23(4):565-74.
28. Petrovanu C, Coman AE, Muranu GC, Petrovanu R. Metabolic syndrome and breast cancer risk in post-menopausal women. Rev Med Chir Soc Nat Lasi 2008;112(3):630-4.
29. Amaral P, Miquel P, Mehdad A, et al. Body fat and poor diet in breast cancer women. Nutr Hosp 2010;25(3):456-61.
30. Loi S, Milne RL, Friedlander ML et al. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14(7):1686-91.
31. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20(4): 1128-43.
32. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 2001;92(4):720-9.
33. Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;335(7634):1134.
34. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371(9612):569-78.
35. Feigelson HS, Jonas CR, Teras LR, Thun, MJ, Calle EE. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev 2004; 13(2):220-4.
36. Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst (Bethesda) 1996;88(11):756-8.
37. Travis RC, Key TJ. Oestrogen exposure and breast cancer risk. Breast Cancer Res 2003;5(5):239-47.
38. Jordan S, Lim L, Vilainerun D, et al. Breast cancer in the Thai Cohort Study: an exploratory case-control analysis. Breast 2009;18(5): 299-303.
39. Hu YH, Nagata C, Shimizu H, Kaneda N, Kashiki Y. Association of body mass index, physical activity and reproductive histories with breast cancer: a case control study in Gifu, Japan. Breast Cancer Res Treat 1997;43(1):65-72.
40. Iwasaki M, Otani T, Inoue M, Sasazuki S, Tsugane S. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol 2007;17(4):304-12.
41. Wu MH, Chou YC, Yu JC, et al. Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 2006; 16(3):223-9.
42. Surekha D, Sailaja K, Nageswara Rao D, Padma T, Raghunadharao D, Vishnupriya S. Association of CYP1A1*2 polymorphism with breast cancer risk: a case control study. Indian J Med Sci 2009;63(1): 13-20.
43. Han W, Kang D, Park IA, et al. Association between breast cancer susceptibility gene polymorphism and clinicopathological features. Clin Cancer Res 2004;10:124-30.
44. Henderson RM. The bigger the healthier: are the limits of BMI risk changing over time? Econ Hum Biol 2005; 3(3):339-66.